MEIER, Christoph R. Pharmacoepidemiology – Assessing the Risks and Benefits of Drugs in the Postmarketing Phase. CHIMIA, [S. l.], v. 60, n. 1-2, p. 54, 2006. DOI: 10.2533/000942906777675272. Disponível em: https://www.chimia.ch/chimia/article/view/2006_054. Acesso em: 30 apr. 2024.